Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has secured overwhelming shareholder support for a series of funding-related resolutions at its extraordinary general…
Read More

Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has secured overwhelming shareholder support for a series of funding-related resolutions at its extraordinary general…
Read More
Australian immuno-oncology company Imugene (ASX:IMU) has relocated to accelerate development of its lead cancer therapy after reporting encouraging clinical results,…
Read More